Similar articles for PMID: 1588458

Year	Number of Results
1966	1
1981	1
1987	1
1988	1
1989	3
1990	1
1991	2
1992	2
1993	2
1994	3
1995	1
1996	2
1997	2
1999	2
2000	1
2001	1
2003	1
2004	2
2007	2
2008	1
2009	1
2012	1
2013	1
2016	1
2017	1
2019	1
2022	0

1

A novel formulation of an ophthalmic beta-adrenoceptor antagonist.

Weinreb RN, Jani R. Weinreb RN, et al. J Parenter Sci Technol. 1992 Mar-Apr;46(2):51-3. J Parenter Sci Technol. 1992. PMID: 1588458

2

Ion exchange resins for ophthalmic delivery.

Jani R, Gan O, Ali Y, Rodstrom R, Hancock S. Jani R, et al. J Ocul Pharmacol. 1994 Spring;10(1):57-67. doi: 10.1089/jop.1994.10.57. J Ocul Pharmacol. 1994. PMID: 8207345

3

Are there any benefits of Betoptic S (betaxolol HCl ophthalmic suspension) over other beta-blockers in the treatment of glaucoma?

Yarangümeli A, Kural G. Yarangümeli A, et al. Expert Opin Pharmacother. 2004 May;5(5):1071-81. doi: 10.1517/14656566.5.5.1071. Expert Opin Pharmacother. 2004. PMID: 15155109 Review.

4

[Clinical evaluation of betaxolol in ophthalmic suspension with or without preservative agent in patients with glaucoma or ocular hypertension].

Denis P, Demailly P, Saraux H. Denis P, et al. J Fr Ophtalmol. 1993;16(5):297-303. J Fr Ophtalmol. 1993. PMID: 8331248 Clinical Trial. French.

5

Ocular distribution, bactericidal activity and settling characteristics of TobraDex ST ophthalmic suspension compared with TobraDex ophthalmic suspension.

Scoper SV, Kabat AG, Owen GR, Stroman DW, Kabra BP, Faulkner R, Kulshreshtha AK, Rusk C, Bell B, Jamison T, Bernal-Perez LF, Brooks AC, Nguyen VA. Scoper SV, et al. Adv Ther. 2008 Feb;25(2):77-88. doi: 10.1007/s12325-008-0019-9. Adv Ther. 2008. PMID: 18309465

6

Ocular hypotensive efficacy and safety of a combined formulation of betaxolol and pilocarpine.

Robin AL. Robin AL. Trans Am Ophthalmol Soc. 1996;94:89-101; discussion 101-3. Trans Am Ophthalmol Soc. 1996. PMID: 8981691 Free PMC article. Clinical Trial.

7

[Nanocapsules of beta-blocking agents: a new drug carrier in ophthalmology. Application to medical treatment of glaucoma in rabbits].

Marchal-Heussler L, Sirbat D, Hoffman M, Maincent P. Marchal-Heussler L, et al. J Fr Ophtalmol. 1991;14(6-7):371-5. J Fr Ophtalmol. 1991. PMID: 1685738 French.

8

Ocular-specific chemical delivery systems of betaxolol for safe local treatment of glaucoma.

Farag HH, Wu WM, Barros MD, Somogyi G, Prokai L, Bodor N. Farag HH, et al. Drug Des Discov. 1997 Aug;15(2):117-30. Drug Des Discov. 1997. PMID: 9342554

9

The comparative cardiovascular, pulmonary, ocular blood flow, and ocular hypotensive effects of topical travoprost, bimatoprost, brimonidine, and betaxolol.

Inan UU, Ermis SS, Orman A, Onrat E, Yucel A, Ozturk F, Asagidag A, Celik A. Inan UU, et al. J Ocul Pharmacol Ther. 2004 Aug;20(4):293-310. doi: 10.1089/1080768041725344. J Ocul Pharmacol Ther. 2004. PMID: 15321024 Clinical Trial.

10

Effect of long-term topical betaxolol on tissue circulation in the iris and optic nerve head.

Araie M, Muta K. Araie M, et al. Exp Eye Res. 1997 Feb;64(2):167-72. doi: 10.1006/exer.1996.0193. Exp Eye Res. 1997. PMID: 9176049

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed